Efficacy of the Integration of Digital Therapeutics and Home-based Cardiac Rehabilitation in High-Risk Post-PCI Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions
Coronary Artery DiseaseMyocardial Infarction
Interventions
OTHER

DTx-guided HBCR

The Huaxiaoxin WeChat mini program incorporating the core components of guidelines are divided into two main sections. Section 1 comprises interventions such as exercise training, educational programmes and cardiovascular risk factor management. Section 2 provides a secure platform for individualized feedback, just-in-time two-way communication, remote data transmission, and data repository, allowing patients and healthcare providers to access all relevant files anytime and anywhere throughout the 12-month study period.

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT06542575 - Efficacy of the Integration of Digital Therapeutics and Home-based Cardiac Rehabilitation in High-Risk Post-PCI Patients | Biotech Hunter | Biotech Hunter